Clinical Trials of COVID-19 Therapies Should Account for Diabetes and Hyperglycemia

被引:0
作者
Klonoff, David C. [1 ]
Messler, Jordan [2 ]
Valk, Timothy [3 ]
Jagannathan, Ram [4 ]
Pasquel, Francisco J. [4 ]
Umpierrez, Guillermo E. [4 ]
机构
[1] Mills Peninsula Med Ctr, San Mateo, CA USA
[2] Glytec, Waltham, MA USA
[3] Admetsys Corp, Div Res, Winter Pk, FL USA
[4] Emory Univ, Sch Med, Atlanta, GA USA
来源
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY | 2021年 / 15卷 / 05期
关键词
diabetes; COVID-19; hospital; clinical trial; antiviral; hyperglycemia;
D O I
10.1177/19322968211013369
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Complications of Coronavirus Disease 2019 (COVID-19) occur with increased frequency in people admitted to the hospital with diabetes or hyperglycemia. The increased risk for COVID-19 infections in the presence of these metabolic conditions is in part due to overlapping pathophysiologic features of COVID-19, diabetes, and glucose control. Various antiviral treatments are being tested in COVID-19 patients. We believe that in these trials, it will be useful to evaluate treatment effect differences in patients stratified according to whether they have diabetes or hyperglycemia. In this way, it will be possible to better facilitate development of antiviral treatments that are most specifically beneficial for the large subset of COVID-19 patients who have diabetes or hyperglycemia.
引用
收藏
页码:1181 / 1187
页数:7
相关论文
共 56 条
  • [21] Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
    Henry, Brandon Michael
    de Oliveira, Maria Helena Santos
    Benoit, Stefanie
    Plebani, Mario
    Lippi, Giuseppe
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (07) : 1021 - 1028
  • [22] Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
  • [23] Clinical Characteristics, Treatment, and Outcomes of Critically Ill Patients With COVID-19: A Scoping Review
    Huang, Chanyan
    Soleimani, Jalal
    Herasevich, Svetlana
    Pinevich, Yuliya
    Pennington, Kelly M.
    Dong, Yue
    Pickering, Brian W.
    Barwise, Amelia K.
    [J]. MAYO CLINIC PROCEEDINGS, 2021, 96 (01) : 183 - 202
  • [24] Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome
    Hue, Sophie
    Beldi-Ferchiou, Asma
    Bendib, Ines
    Surenaud, Mathieu
    Fourati, Slim
    Frapard, Thomas
    Rivoal, Simon
    Razazi, Keyvan
    Carteaux, Guillaume
    Delfau-Larue, Marie-Helene
    Mekontso-Dessap, Armand
    Audureau, Etienne
    de Prost, Nicolas
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 202 (11) : 1509 - 1519
  • [25] Iughetti Lorenzo, 2020, Acta Biomed, V91, pe2020033, DOI 10.23750/abm.v91i3.10366
  • [26] Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19
    Kazancioglu, Sumeyye
    Yilmaz, Fatma Meric
    Bastug, Aliye
    Sakalli, Arzu
    Ozbay, Bahadir Orkun
    Buyuktarakci, Cansu
    Bodur, Hurrem
    Yilmaz, Gulsen
    [J]. VIRAL IMMUNOLOGY, 2021, 34 (05) : 342 - 351
  • [27] Association Between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients With COVID-19: A Multicenter, Retrospective Hospital-Based Analysis
    Klonoff, David C.
    Messler, Jordan C.
    Umpierrez, Guillermo E.
    Peng, Limin
    Booth, Robby
    Crowe, Jennifer
    Garrett, Valerie
    McFarland, Raymie
    Pasquel, Francisco J.
    [J]. DIABETES CARE, 2021, 44 (02) : 578 - 585
  • [28] CD14+ Monocytes Are Vulnerable and Functionally Impaired Under Endoplasmic Reticulum Stress in Patients With Type 2 Diabetes
    Komura, Takuya
    Sakai, Yoshio
    Honda, Masao
    Takamura, Toshinari
    Matsushima, Kouji
    Kaneko, Shuichi
    [J]. DIABETES, 2010, 59 (03) : 634 - 643
  • [29] Impact of blood glucose abnormalities on outcomes and disease severity in patients with severe sepsis: An analysis from a multicenter, prospective survey of severe sepsis
    Kushimoto, Shigeki
    Abe, Toshikazu
    Ogura, Hiroshi
    Shiraishi, Atsushi
    Saitoh, Daizoh
    Fujishima, Seitaro
    Mayumi, Toshihiko
    Hifumi, Toru
    Shiino, Yasukazu
    Nakada, Taka-aki
    Tarui, Takehiko
    Otomo, Yasuhiro
    Okamoto, Kohji
    Umemura, Yutaka
    Kotani, Joji
    Sakamoto, Yuichiro
    Sasaki, Junichi
    Shiraishi, Shin-ichiro
    Takuma, Kiyotsugu
    Tsuruta, Ryosuke
    Hagiwara, Akiyoshi
    Yamakawa, Kazuma
    Masuno, Tomohiko
    Takeyama, Naoshi
    Yamashita, Norio
    Ikeda, Hiroto
    Ueyama, Masashi
    Fujimi, Satoshi
    Gando, Satoshi
    [J]. PLOS ONE, 2020, 15 (03):
  • [30] High admission blood glucose independently predicts poor prognosis in COVID-19 patients: A systematic review and dose-response meta-analysis
    Lazarus, Gilbert
    Audrey, Jessica
    Wangsaputra, Vincent Kharisma
    Tamara, Alice
    Tahapary, Dicky L.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 171